Corticotropin-releasing factor (CRF) in stress and disease: A review of literature and treatment perspectives with special emphasis on psychiatric disorders
The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Kine Krohga, Ida Hagemana & Martin Balslev Jørgensen D.M.Sc M.Da*a Department of Psychiatry, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark† Correspondence: Martin Balslev Jørgensen, Department of Psychiatry, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark martinbj@rh.regionh.dkThe CRF family of neuropeptides and receptors is involved in a variety of stress responses, in the regulation of appetite, metabolic and inflammatory processes as well as intestinal movements. From a primarily psychiatric perspective, the present paper reviews the literature on its anatomy, physiology and its involvement in psychiatric, neurological and inflammatory diseases. Finally, recent developments in the pharmacological aspects of CRF in these diseases are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRF-ergic activation promotes secretion of NE by the LC [184, 185]”
From Sleep and REM sleep disturbance in the pathophysiology of PTSD: the role of extinction memory (2015) · cites this paper as [185]
Citations
Cites
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Heim, C. (2000) · JAMA · doi:10.1001/jama.284.5.592 · Cited by 1,968 · cited 1×
“A parallel study (17) found that abused women exhibited increased Table 1.”
BackgroundHippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590 · cited 1×
“Depressed patients show pituitary (25) and adrenal gland hypertrophy (26), and hippocampal atrophy (27, 28).”
BackgroundNemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 1×
“Depressive patients, not yet pharmacologically treated, show elevated concentrations of CRF in the CSF (32), elevated CRF concentrations in PVN (33) and down-regulation of CRFR1 in the frontal cortex (34).”
BackgroundSheline, Y. I., Sanghavi, M., Mintun, M. A., & Gado, M. H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05034.1999 · Cited by 1,382 · cited 2×
“The hippocampal atrophy appears to be associated with the duration and number of depressive episodes (29).”
BackgroundThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · cited 3×
“CRF induces an increase in the NA activity in LC, early life stress leads to an increase of CRF in the LC, and benzodiazepines reduce the concentration of CRF in the LC (9, 43).”
BackgroundChronic stress and obesity: a new view of “comfort food”
Dallman, M. F., Pecoraro, N., Akana, S. F., la Fleur, S. E., Gomez, F., Houshyar, H., Bell, M. E., Bhatnagar, S., Laugero, K. D., & Manalo, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934666100 · Cited by 1,369 · cited 3×
“In addition, ‘‘comfort food’’ is often rich on carbohydrates, leading to stimulation of serotonin production (11, 46, 53).”
BackgroundDunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980 · cited 1×
“The exact mechanism behind this atrophy is not fully elucidated, but several pre-clinical studies have shown that high concentrations of cortisol can inhibit neurogenesis and cause neuronal atrophy and death in hippocampus (27, 30, 31).”
BackgroundSmith, G. W., Aubry, J.-M., Dellu, F., Contarino, A., Bilezikjian, L. M., Gold, L. H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C. A., et al. (1998) · Neuron · doi:10.1016/s0896-6273(00)80491-2 · Cited by 892 · cited 1×
“Transgenic mouse models suggest that CRFR1 specifically mediates the anxiogenic effect of CRF (44, 45).”
BackgroundBale, T. L., Contarino, A., Smith, G. W., Chan, R., Gold, L. H., Sawchenko, P. E., Koob, G. F., Vale, W. W., & Lee, K.-F. (2000) · Nature Genetics · doi:10.1038/74263 · Cited by 849
Gold, P. W., Loriaux, D. L., Roy, A., Kling, M. A., Calabrese, J. R., Kellner, C. H., Nieman, L. K., Post, R. M., Pickar, D., Gallucci, W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605223142101 · Cited by 766
Heim, C., Newport, D. J., Bonsall, R., Miller, A. H., & Nemeroff, C. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.575 · Cited by 746
Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death
Sapolsky, R. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00971-9 · Cited by 699 · cited 1×
“The exact mechanism behind this atrophy is not fully elucidated, but several pre-clinical studies have shown that high concentrations of cortisol can inhibit neurogenesis and cause neuronal atrophy and death in hippocampus (27, 30, 31).”
BackgroundStress and the inflammatory response: A review of neurogenic inflammation
Black, P. H. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00021-1 · Cited by 688
(2000) · PubMed · Cited by 676
Posttraumatic stress disorder: a state-of-the-science review
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., & Stein, M. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.005 · Cited by 675
Raadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · cited 1×
“Data from pre-clinical and clinical studies suggest that CRF1 receptor antagonists represent new therapeutic agents in the treatment of affective and anxiety-related diseases (80, 81).”
BackgroundCoplan, J. D., Andrews, M. W., Rosenblum, L. A., Owens, M. J., Friedman, S., Gorman, J. M., & Nemeroff, C. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1619 · Cited by 649 · cited 1×
“Early life stress can lead to chronic changes in the CRF system, and to development of depressive and anxietyrelated psychopathology in adults (15).”
BackgroundEarly life experience alters response of adult neurogenesis to stress
Mirescu, C., Peters, J. D., & Gould, E. (2004) · Nature Neuroscience · doi:10.1038/nn1290 · Cited by 625 · cited 2×
“In one study, adult rats exposed to maternal separation as pups, had decreased neurogenesis in the hippocampus (19).”
Background(1962) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1962.tb27008.x · Cited by 586
Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims
Nemeroff, C. B. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300075009 · Cited by 555
The CRF peptide family and their receptors: yet more partners discovered
Dautzenberg, F. M., & Hauger, R. L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)01946-6 · Cited by 532
Plotsky, P. M., Thrivikraman, K. V., Nemeroff, C. B., Caldji, C., Sharma, S., & Meaney, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300769 · Cited by 522 · cited 1×
“In addition, changes in the extrahypothalamic CRF systems, such as increased CRF receptor concentration in DRN, and increased CRF concentration in CNA and LC, have been found (18).”
BackgroundHeim, C., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00224-3 · Cited by 502 · cited 1×
“In patients with PD and GAD, no consistent changes in CSF CRF have been found (52).”
BackgroundDe Souza, E. B. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00011-9 · Cited by 395
Taché, Y., Martinez, V., Million, M., & Wang, L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.2.g173 · Cited by 347
CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.873 · Cited by 336
Liebsch, G., Montkowski, A., Holsboer, F., & Landgraf, R. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00198-8 · Cited by 328
Alonso, R., Griebel, G., Pavone, G., Stemmelin, J., Le Fur, G., & Soubrié, P. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001464 · Cited by 319
The role of stress in the pathophysiology of the dopaminergic system
Pani, L., Porcella, A., & Gessa, G. L. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000589 · Cited by 313
Kirby, L. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00093-7 · Cited by 307
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.656 · Cited by 278
Nemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 254
KRISHNAN, K. R. R., DORAISWAMY, P. M., LURIE, S. N., FIGIEL, G. S., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., & NEMEROFF, C. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-256 · Cited by 232
Effects of Corticotropin-Releasing Factor on Brain Serotonergic Activity
Price, B. A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00197-8 · Cited by 226
Crofford, L. J., Sano, H., Karalis, K., Friedman, T. C., Epps, H. R., Remmers, E. F., Mathern, P., Chrousos, G. P., & Wilder, R. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1587 · Cited by 216
Rubin, R. T. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150045009 · Cited by 208
Richard, D., Lin, Q., & Timofeeva, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01428-0 · Cited by 205
HEIM, C., OWENS, M. J., PLOTSKY, P. M., & NEMEROFF, C. B. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48279.x · Cited by 197
Altemus, M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 188
Smoller, J. W., Yamaki, L. H., Fagerness, J. A., Biederman, J., Racette, S., Laird, N. M., Kagan, J., Snidman, N., Faraone, S. V., Hirshfeld-Becker, D., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.018 · Cited by 168
Licinio, J., O'Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Lake, S., Tantisira, K. G., Weiss, S. T., & Wong, M.-L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001587 · Cited by 168
Tandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168
Adrenal Cortical Activity in Depressive Illness
CARPENTER, W. T., & BUNNEY, W. E. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.128.1.31 · Cited by 166
Melatonin in Medically Ill Patients With Insomnia: A Double-Blind, Placebo-Controlled Study
Andrade, C., Srihari, B. S., Reddy, K. P., & Chandramma, L. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0109 · Cited by 158
Recollection of Childhood Events in Adults with Irritable Bowel Syndrome
Lowman, B. C., Drossman, D. A., Cramer, E. M., & McKee, D. C. (1987) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198706000-00017 · Cited by 147
Kunzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., Ising, M., & Holsboer, F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00070-0 · Cited by 142
HPA axis dysregulation in mice overexpressing corticotropin releasing hormone
Groenink, L., Dirks, A., Verdouw, P. M., Schipholt, M. L., Veening, J. G., van der Gugten, J., & Olivier, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01334-3 · Cited by 140
Sensitivity to stress: Dysregulation of CRF pathways and disease development
Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 135
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Holsboer, F., Gerken, A., von Bardeleben, U., Grimm, W., Beyer, H., Müller, O. A., & Stalla, G. K. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90121-6 · Cited by 126
Hiroi, N., Wong, M. L., Licinio, J., Park, C., Young, M., Gold, P. W., Chrousos, G. P., & Bornstein, S. R. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000908 · Cited by 124 · cited 1×
“Probably connected to this, post mortem studies in suicide victims show down-regulation of CRFR1 in the frontal cortex (34), as well as a shift in the CRFR1/CRF2 ratio in the pituitary (37).”
BackgroundAguilera, G., MILLAN, M. A., Hauger, R. L., & Catt, K. J. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24950.x · Cited by 119
Whitehouse, P. J., Vale, W. W., Zweig, R. M., Singer, H. S., Mayeux, R. P., Kuhar, M. J., Price, D. L., & Souza, E. B. D. (1987) · Neurology · doi:10.1212/wnl.37.6.905 · Cited by 119
Chen, Wilcoxen, K. M., Huang, C. Q., Xie, Y.-F., McCarthy, J. R., Webb, T. R., Zhu, Y.-F., Saunders, J., Liu, X.-J., Chen, T.-K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040058e · Cited by 116
la Fleur, S. E., Wick, E. C., Idumalla, P. S., Grady, E. F., & Bhargava, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408531102 · Cited by 107
The dexamethasone suppression test in the clinical setting
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.5.586 · Cited by 90
Gravanis, A., & Margioris, A. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054039008 · Cited by 89
Stress, antidepressant drugs, and the locus coeruleus
Brady, L. S. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90168-6 · Cited by 86
Chappell, P., Leckman, J., Goodman, W., Bissette, G., Pauls, D., Anderson, G., Riddle, M., Scahill, L., McDougle, C., & Cohen, D. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00221-9 · Cited by 85
Risch, S. C., Lewine, R. J., Kalin, N. H., Jewart, R. D., Risby, E. D., Caudle, J. M., Stipetic, M. D., Turner, J., Eccard, M. B., & Pollard, W. E. (1992) · PubMed · Cited by 78
Eating behavior in anorexia nervosa—an excess of both orexigenic and anorexigenic signalling?
Inui, A. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000944 · Cited by 73
The Hypothalamus—pituitary—adrenal axis in depression
Carroll, B. J. (1977) · Elsevier eBooks · doi:10.1016/b978-1-4831-3140-5.50022-3 · Cited by 73
Newcomer, J. W., Faustman, W. O., Whiteford, H. A., Moses, J. A., & Csernansky, J. G. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90052-n · Cited by 61
Claes, S. J., Villafuerte, S. M., Forsgren, T., Sluijs, S., Del‐Favero, J., Adolfsson, R., & Broeckhoven, C. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00425-6 · Cited by 55
Izzo, E., Sanna, P. P., & Koob, G. F. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.04.017 · Cited by 54
Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?
Nielsen, D. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.003 · Cited by 54
Behan, D. P., Khongsaly, O., Owens, M. J., Chung, H. D., Nemeroff, C. B., & De Souza, E. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052053.x · Cited by 53
Neuroendocrine Function and Chronic Inflammatory Stress
Harbuz, M. (2002) · Experimental Physiology · doi:10.1113/eph8702411 · Cited by 53
Kawata, M., Hashimoto, K., Takahara, J., & Sano, Y. (1982) · Anatomy and Embryology · doi:10.1007/bf00305569 · Cited by 51
Evans, R. C. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.5.669-b · Cited by 51
Central mechanisms involved with catabolism
Nandi, J., Meguid, M. M., Inui, A., Xu, Y., Makarenko, I. G., Tada, T., & Chen, C. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00010 · Cited by 47
Evans, R. C. (1983) · PubMed · Cited by 46
New directions in the development of antidepressants: the interface of neurobiology and psychiatry
Nemeroff, C. B. (2002) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.396 · Cited by 45
Are CRF receptor antagonists potential antidepressants?
O'Brien, D., Skelton, K. H., Owens, M. J., & Nemeroff, C. B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.187 · Cited by 45
Challis, B., Luan, J., Keogh, J. M., Wareham, N. J., Farooqi, I. S., & O’Rahilly, S. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802564 · Cited by 39
Nishino, S., Mignot, E., Benson, K. L., & Zarcone, Jr. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00012-2 · Cited by 39
Forman, S. D., Bissette, G., Yao, J., Nemeroff, C. B., & van Kammen, D. P. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90083-3 · Cited by 23
Should the dexamethasone suppression test be resurrected?
Scandinavica, A. P., & Fink, M. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00628.x · Cited by 23
Neuroendocrine Differences among Subtypes of Schizophrenic Disorder?
Bánki, C. M., Arató, M., & Ríhmer, Z. (2008) · Neuropsychobiology · doi:10.1159/000118072 · Cited by 22
The stressed gut: Contributions of intestinal stress peptides to inflammation and motility
Bunnett, N. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503092102 · Cited by 21
Mj, G., Kahn, J. P., Laxenaire, M., Nicolas, J. P., & Burlet, C. R. (1994) · PubMed · Cited by 20
Relationship between DST nonsuppression and shortened REM latency in schizophrenia
Tandon, R., Lewis, C. F., Taylor, S. F., Shipley, J. E., DeQuardo, J. R., Jibson, M. D., & Goldman, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(96)00205-3 · Cited by 19
Dexamethasone nonsuppression in chronic schizophrenia
Whiteford, H., Riney, S. J., Savala, R. A., & Csernansky, J. G. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05077.x · Cited by 18
Conti, L. H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.055 · Cited by 17
Monteleone, P., Luisi, M., Martiadis, V., Serritella, C., Longobardi, N., Casarosa, E., Genazzani, A. R., & Maj, M. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.08.015 · Cited by 14
Research works printed but not linked: 3
- De Souza EB, 1995, Psychopharmacology: The fourth generation of progess, 505
- Gross MJ, 1994, Ann Endocrinol (Paris), 55, 221
- Risch SC, 1992, Neuropsychopharmacology, 6, 95
Cited by
Sleep and REM sleep disturbance in the pathophysiology of PTSD: the role of extinction memory
Pace-Schott, E. F., Germain, A., & Milad, M. R. (2015) · Biology of Mood & Anxiety Disorders · doi:10.1186/s13587-015-0018-9 · Cited by 255
“CRF-ergic activation promotes secretion of NE by the LC [184, 185].”
BackgroundThe influence of sleep on fear extinction in trauma-related disorders
Pace-Schott, E. F., Seo, J., & Bottary, R. M. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100500 · Cited by 55
Wagle, M. D., Mathur, P., & Guo, S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3339-10.2011 · Cited by 47
Rivier, J., & RIVIER, C. L. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.10.006 · Cited by 38
Zhang, B. (2017) · PubMed Central · doi:10.13918/j.issn.2095-8137.2017.002 · Cited by 34
Metadata
- Authors
- Krohg, K., Hageman, I., & Balslev Jørgensen, M.
- Affiliations
- Copenhagen University Hospital (DK)
- ORCID
- Hageman, Ida
- Venue
- Nordic Journal of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 62
- Issue
- 1
- Pages
- 8-16
- ISSN
- 0029-1455 (ISSN-L)
- 0803-9488
- 1502-4725
- OpenAlex
- W2070935995
- Cited by
- 18
- References
- 92
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2015: 3 · 2013: 1 · 2012: 2
- FWCI
- 0.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nordic Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, CRF receptors, stress response, mental illness, neuroinflammation, inflammatory diseases, neurological disorders, appetite regulation, neuropeptides
- MeSH terms
- CRF Receptor, Type 1, Adrenocorticotropic Hormone, Amygdala, Appetite, Mental Disorders, Brain Stem, Corticotropin-Releasing Hormone, Drug Therapy, Energy Metabolism, Feeding Behavior, Hippocampus, Humans, Hypothalamo-Hypophyseal System, Inflammation, Locus Coeruleus, Neuropeptides, Pituitary-Adrenal System, Spinal Cord, Stress, Psychological, Receptors, Corticotropin-Releasing Hormone, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.